Mechanistic pathways underlying the antihypertensive effect of fermented milk with Lactococcus lactis NRRL b-50571 in spontaneously hypertensive rats

Nutrients

Volumn 10, Issue 3, 2018, Pages

  Beltrán Barrientos, Lilia M ^a   Hernández Mendoza, Adrián ^a   González Córdova, Aarón F ^a   Astiazarán García, Humberto ^a   Esparza Romero, Julián ^a   Vallejo Córdoba, Belinda ^a  

^a CENTRO DE INVESTIGACIÓN EN ALIMENTACIÓN Y DESARROLLO   (Mexico)

Author keywords

Angiotensin converting enzyme inhibition; Antioxidant activity; Fermented milk; Lactococcus lactis; Nitric oxide; Opioid effect

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; NALOXONE; CATALASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NARCOTIC ANTAGONIST; NITRIC OXIDE; OPIATE RECEPTOR; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; LACTOCOCCUS LACTIS; LIPID PEROXIDATION ASSAY; MALE; MILK; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; BLOOD; BLOOD PRESSURE; DIET; DRUG EFFECT; FERMENTED MILK PRODUCT; HYPERTENSION; LIPID PEROXIDATION; METABOLISM; OXIDATIVE STRESS; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAPTOPRIL; CATALASE; CULTURED MILK PRODUCTS; DIET; GLUTATHIONE PEROXIDASE; HYPERTENSION; LACTOCOCCUS LACTIS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NALOXONE; NARCOTIC ANTAGONISTS; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RECEPTORS, OPIOID; SUPEROXIDE DISMUTASE;

EID: 85042561574     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu10030262     Document Type: Article

References (38)

1. O’Shea, P.M.; Griffin, T.P.; Fitzgibbon, M. Hypertension: The role of biochemistry in the diagnosis and management. Clin. Chim. Acta 2017, 465, 131–143. [CrossRef] [PubMed]
2. Miller, G.D.; Jarvis, J.K.; McBean, L.D. Dairy foods and hypertension. In Handbook of Dairy Foods and Nutrition, 3rd ed.; CRC Press: Boca Raton, FL, USA, 2007; pp. 99–139.
3. Flambard, B.; Johansen, E. Developing a functional dairy product: From research on Lactobacillus helveticus to industrial application of Cardi-04TM in novel antihypertensive drink yogurts. In Functional Dairy Products; Saarela, M., Ed.; CRC Press LLC: Boca Raton, FL, USA, 2007; pp. 506–520.
4. Beltrán-Barrientos, L.M.; Hernández-Mendoza, A.; Torres-Llanez, M.J.; González-Córdova, A.F.; Vallejo-Córdoba, B. Invited review: Fermented milk as antihypertensive functional food. J. Dairy Sci. 2016, 99, 4099–4110. [CrossRef] [PubMed]
5. Ebringer, L.; Ferencik, M.; Krajcovic, J. Beneficial health effects of milk and fermented dairy products. Folia Microbiol. (Praha) 2008, 53, 378–394. [CrossRef] [PubMed]
6. González-Córdova, A.F.; Torres-Llanez, M.J.; Rodríguez-Figueroa, J.C.; Espinoza-De-Los-Monteros, J.J.; García, H.S.; Vallejo-Cordoba, B. Actividad inhibidora de la enzima convertidora de angiotensina en leches fermentadas con cepas de Lactobacillus. CYTA J. Food 2011, 9, 146–151. [CrossRef]
7. Mohanty, D.P.; Mohapatra, S.; Misra, S.; Sahu, P.S. Milk derived bioactive peptides and their impact on human health—A review. Saudi J. Biol. Sci. 2016, 23, 577–583. [CrossRef] [PubMed]
8. Udenigwe, C.; Mohan, A. Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition. J. Funct. Foods 2014, 8, 45–52. [CrossRef]
9. Hayakawa, K.; Kimura, M.; Kamata, K. Mechanism underlying gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. Eur. J. Pharmacol. 2002, 438, 107–113. [CrossRef]
10. Perazella, M.A.; Setaro, J.F. Renin-angiotensin-aldosterone system: Fundamental aspects and clinical implications in renal and cardiovascular disorders. J. Nucl. Cardiol. 2003, 10, 184–196. [CrossRef] [PubMed]
11. Del Mar Contreras, M.; Carron, R.; Montero, M.J.; Ramos, M.; Recio, I. Novel casein-derived peptides with antihypertensive activity. Int. Dairy J. 2009, 19, 566–573. [CrossRef]
12. Yamaguchi, N.; Kawaguchi, K.; Yamamoto, N. Study of the mechanism of antihypertensive peptides VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis. Eur. J. Pharmacol. 2009, 620, 71–77. [CrossRef] [PubMed]
13. Nurminen, M.L.; Sipola, M.; Kaarto, H.; Pihlanto-Leppala, A.; Piilola, K.; Korpela, R.; Tossavainen, O.; Korhonen, H.; Vapaatalo, H. α-Lactorphin lowers blood pressure measured radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci. 2000, 66, 1535–1543. [CrossRef]
14. Rodríguez-Figueroa, J.C.; Reyes-Díaz, R.; González-Córdova, A.F.; Troncoso-Rojas, R.; Vargas-Arispuro, I.; Vallejo-Cordoba, B. Angiotensin-converting enzyme inhibitory activity of milk fermented by wild and industrial Lactococcus lactis strains. J. Dairy Sci. 2010, 93, 5032–5038. [CrossRef] [PubMed]
15. Rodríguez-Figueroa, J.C.; González-Córdova, A.F.; Torres-Llanez, M.J.; García, H.S.; Vallejo-Cordoba, B. Novel angiotensin I-converting enzyme inhibitory peptides produced in fermented milk by specific wild Lactococcus lactis strains. J. Dairy Sci. 2012, 95, 5536–5543. [CrossRef] [PubMed]
16. Rodríguez-Figueroa, J.C.; González-Córdova, A.F.; Astiazarán-Gacía, H.; Vallejo-Córdoba, B. Hypotensive and heart rate lowering effects in rats receiving milk fermented by specific Lactococcus lactis strains. Br. J. Nutr. 2013, 109, 827–833. [CrossRef] [PubMed]
17. Rodríguez-Figueroa, J.C.; González-Córdova, A.F.; Astiazarán-Gacía, H.; Vallejo-Cordoba, B. Antihypertensive and hypolipidemic effect of milk fermented by specific Lactococcus lactis strains. J. Dairy Sci. 2013, 96, 4094–4099. [CrossRef] [PubMed]
18. Beltrán-Barrientos, L.M.; González-Córdova, A.F.; Hernández-Mendoza, A.; Torres-Inguanzo, E.H.; Astiazarán-García, H.; Esparza-Romero, J.; Vallejo-Córdoba, B. Randomized double-blind controlled clinical trial of the blood pressure lowering effect of fermented milk with Lactococcus lactis: A pilot study. J. Dairy Sci. 2018. [CrossRef] [PubMed]
19. Beltrán-Barrientos, L.M.; Estrada-Montoya, C.; Reyes-Díaz, R.; Hernández-Mendoza, A.; González-Córdova, A.F.; Vallejo-Córdoba, B. Assessment of the potential role of gamma-aminobutyric acid on the antihypertensive effect of fermented milk with Lactococcus lactis NRRL B-50571. J. Funct. Foods 2018, in press.
20. Okamoto, K.; Aoki, K. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 1963, 27, 282–293. [CrossRef] [PubMed]
21. Cushman, D.W.; Cheng, H.S. Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochem. Pharmacol. 1971, 20, 1637–1648. [CrossRef]
22. Ruas, C.B.G. Oxidative stress biomarkers of exposure in the blood of cichlid species from a metal-contaminated river. Ecotox. Environ. Safe 2008, 71, 86–93. [CrossRef] [PubMed]
23. 2 -triggered G2/M arrest. Eur. Food Res. Technol. 2012, 234, 431–439. [CrossRef]
24. Todorova, I.; Simeonova, G.; Kyuchukova, D.; Dinev, D.; Gadjeva, V. Reference values of oxidative stress parameters (MDA, SOD, CAT) in dogs and cats. Comp. Clin. Pathol. 2005, 13, 190–194. [CrossRef]
25. Hernández-Ledesma, B.; García-Nebot, M.J.; Fernández-Tomé, S.; Amigo, L.; Recio, I. Dairy protein hydrolysates: Peptides for health benefits. Int. Dairy J. 2014, 38, 82–100. [CrossRef]
26. Meisel, H.; FitzGerald, R.J. Opioid peptides encrypted in intact milk protein sequences. Br. J. Nutr. 2000, 84, 27–31. [CrossRef]
27. Manzanares, P.; Salom, J.B.; García-Tejedor, A.; Fernández-Musoles, R.; Ruiz-Jiménez, P.; Gimeno-Alcañiz, J.V. Unraveling the mechanisms of action of lactoferrin-derived antihypertensive peptides: ACE inhibition and beyond. Food Funct. 2015, 6, 2440–2452. [CrossRef] [PubMed]
28. Fernández-Musoles, R.; Manzanares, P.; Burguete, M.C.; Alborch, E.; Salom, J.B. In vivo angiotensin I-converting enzyme inhibition by long-term intake of antihypertensive lactoferrin hydrolysate in spontaneously hypertensive rats. Food Res. Int. 2013, 54, 627–632. [CrossRef]
29. Ruiz-Giménez, P.; Ibáñez, A.; Salom, J.B.; Marcos, J.F.; López-Díez, J.J.; Vallés, S.; Torregrosa, G.; Alborch, E.; Manzanares, P. Antihypertensive properties of lactoferricin B-derived peptides. J. Agric. Food Chem. 2010, 58, 6721–6727. [CrossRef] [PubMed]
30. Majumder, K.; Wu, J. Molecular targets of antihypertensive peptides: understanding the mechanisms of action based on the pathophysiology of hypertension. Int. J. Mol. Sci. 2015, 16, 256–283. [CrossRef] [PubMed]
31. Chakrabarti, S.; Wu, J. Bioactive peptides on endothelial function. Food Sci. Hum. Wellness 2016, 5, 1–7. [CrossRef]
32. Ceriello, A. Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 2008, 31, 181–184. [CrossRef] [PubMed]
33. Kim, S.M.; Park, S.; Choue, R. Effects of fermented milk peptides supplement on blood pressure and vascular function in spontaneously hypertensive rats. Food Sci. Biotechnol. 2010, 19, 1409–1413. [CrossRef]
34. Yuan, W.; Wang, J.; Zhou, F. In vivo hypotensive and physiological effects of a silk fibroin hydrolysate on spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 2012, 76, 1987–1989. [CrossRef] [PubMed]
35. Erdmann, K.; Cheung, B.W.Y.; Schroder, H. The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. J. Nutr. Biochem. 2008, 19, 643–654. [CrossRef] [PubMed]
36. Sarmadi, B.H.; Ismail, A. Antioxidative peptides from food proteins: A review. Peptides 2010, 31, 1949–1956. [CrossRef] [PubMed]
37. Hsieh, C.C.; Hernández-Ledesma, B.; Fernández-Tolomé, S.; Weinborn, V.; Barile, D.; de Moura, J.M.L. Milk proteins, peptides, and oligosaccharides: Effects against the 21st century disorders. BioMed. Res. Int. 2015. [CrossRef] [PubMed]
38. Park, E.; Seo, B.Y.; Yoon, Y.C.; Lee, S.M. Beneficial effects of hydrolysates of whey proteins in spontaneously hypertensive rats. J. Food Nutr. Res. 2017, 5, 794–800. [CrossRef]